A lack of validated preclinical models for exploring cellular mechanisms has limited treatment development in severe autism. In order to develop new preclinical models and therapeutics, rig- orous studies of cell phenotypes and cellular responses to potential agents in patient-derived neurons will be advantageous. The long-term goal of this research is to elucidate the molecular mechanisms underlying the pathology of severe autism that will serve as the basis to develop innovative treatments for these patients with few current therapeutic options. We recently identi- fied a novel mechanism in autism involving endosomal Na+/H+ exchangers (NHEs). We have now generated induced pluripotent stem cell lines (iPSCs) from patients with a range of NHE6 mutations. The objective for this application is to elucidate the role of NHE6 in human axon de- velopment and to test the response of patient-derived neurons to available, mechanism-based agents that may subsequently serve as treatments in patients. NHE6 regulates the efflux of pro- tons from endosomes. In our preliminary studies in human neurons, NHE6 deficiency leads to over-acidification of the endosomal lumen and defects in axon growth and branching. This mechanism is fortuitous because there are a number of well-known FDA-approved agents that target intra-endosomal pH. Our central hypothesis is that deficiency of NHE6 inhibits axon growth and branching due to diminished polarized membrane addition. The rationale for this re- search is that it constitutes the first critical steps toward the development of new treatments for individuals with severe autism and related disorders caused by reductions in NHE6 expression and/or by defects in axonal growth or arborization. We have published studies on NHE6 function in mouse models, yet the transition to patient-derived tissues is warranted at this time. Screening of potential human therapeutic agents is best performed on human (and patient-derived) tis- sues.
Three specific aims are proposed: (1) Determine the role of NHE6 in regulating endosome lumen acidity and endosome recycling. (2) Determine the extent to which the function of RAB10-associated SVs in axon growth is perturbed by NHE6 mutation in patient-derived neu- rons. (3) Determine the reversibility of axon growth and branching defects in patient-derived neurons by exogenous growth factors. The proposed research is innovative because we are studying a novel cellular mechanism in autism, namely, regulation of intra-endosomal pH in ax- on growth. This research is significant because it will lead to the development of critically need- ed preclinical models in patient-derived neurons and potential treatments for severe autism and related disorders, an urgent public health problem.

Public Health Relevance

The proposed research is relevant to public health because autism spectrum disorders (ASDs) are common and associated with high costs to both family and society. The cellular mechanisms under investigation in this proposal govern formation of long-range neuronal circuitry, a process thought to be defective in ASDs. This proposal is relevant to the part of the NIMH Strategic Plan that pertains to the translation of basic mechanisms of mental disorders into innovative treatments for these illnesses.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Developmental Brain Disorders Study Section (DBD)
Program Officer
Panchision, David M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brown University
Schools of Medicine
United States
Zip Code
Schwede, Matthew; Nagpal, Shailender; Gandal, Michael J et al. (2018) Strong correlation of downregulated genes related to synaptic transmission and mitochondria in post-mortem autism cerebral cortex. J Neurodev Disord 10:18
Bayta?, Ozan; Morrow, Eric M (2018) The Role of Mitochondrial Glutamate Metabolism in Cognitive Development and Disease. Neuropsychopharmacology 43:229-230
Xu, Meiyu; Ouyang, Qing; Gong, Jingyi et al. (2017) Mixed Neurodevelopmental and Neurodegenerative Pathology in Nhe6-Null Mouse Model of Christianson Syndrome. eNeuro 4:
Ma, Li; Ouyang, Qing; Werthmann, Gordon C et al. (2017) Live-cell Microscopy and Fluorescence-based Measurement of Luminal pH in Intracellular Organelles. Front Cell Dev Biol 5:71
van Dyck, Laura I; Morrow, Eric M (2017) Genetic control of postnatal human brain growth. Curr Opin Neurol 30:114-124
Young-Pearse, Tracy L; Morrow, Eric M (2016) Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunities. Curr Opin Neurobiol 36:66-73
Howe, Yamini J; O'Rourke, Julia A; Yatchmink, Yvette et al. (2015) Female Autism Phenotypes Investigated at Different Levels of Language and Developmental Abilities. J Autism Dev Disord 45:3537-49
Siegel, Matthew; Smith, Kahsi A; Mazefsky, Carla et al. (2015) The autism inpatient collection: methods and preliminary sample description. Mol Autism 6:61
Gamsiz, Ece D; Sciarra, Laura N; Maguire, Abbie M et al. (2015) Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms. Neurotherapeutics 12:553-71
Brennand, Kristen J; Marchetto, M Carol; Benvenisty, Nissim et al. (2015) Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders. Stem Cell Reports 5:933-945

Showing the most recent 10 out of 12 publications